NCT06795412
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06795412
Title Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pyxis Oncology, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Diego RECRUITING San Diego California 92093 United States Details
Sarcoma Oncology Center RECRUITING Santa Monica California 90403 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
University of Texas - M.D. Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Oncology Houston RECRUITING Houston Texas 77054 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field